TMDX Positive Sentiment
TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Tuesday, December 30, 2025 BiopharmaWatch Research 1 min read Key Takeaway: TransMedics Group, Inc. will present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026. The presentation will highlight the company's advancements in organ transplant therapy for patients with end-stage organ failure. A live webcast of the event will be available on their investor website.
Full Press Release Details
ANDOVER, Mass.,Dec. 30, 2025/PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq:TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will present at the upcoming 44thAnnual J.P. Morgan Healthcare Conference. The presentation will take place on Monday, January 12, 2026, at 3:00 pm Pacific Standard Time / 6:00 pm Eastern Standard Time.
Event: 44thAnnual J.P. Morgan Healthcare ConferenceDate: Monday, January 12, 2026Time: 3:00 pm PST
A live and archived webcast of the presentations will be available on the "Investors" section of the TransMedics website at
https://investors.transmedics.com/. The Company's standard investor presentation is also available through this link.
About TransMedics Group, Inc.TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.
Investor Contact:Brian JohnstonLaine Morgan332-895-3222[email protected]